Clinical trials for Impetigo

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Impetigo. For all clinical trials, go to clinical trials search

This list shows clinical trials for Impetigo

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Impetigo
Title Recruitment status Location
A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections Not Recruiting United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Not Recruiting United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Not Recruiting United Kingdom
Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric patients Not Recruiting United Kingdom
A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infection Study (SOLO I) - SOLO I Not Recruiting United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Not Recruiting United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Not Recruiting United Kingdom
A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Tigecycline Versus Clindamycin for the Treatment of Complicated Skin and Skin Structure Infections, Including Those due to MRSA, in Pediatric Subjects Ages 8 to 17 Years Old Not Recruiting United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Authorised United Kingdom
Evaluation of the effect of an investigational antibiotic (oritavancin) in the treatment of skin and skin structure infections compared to a commonly used antibiotic. Authorised United Kingdom

Page last reviewed:

Next review due: